← Back to headlines
BetterLife Pharma Announces Public Offering for Headache and Migraine Trials
BetterLife Pharma has announced a proposed public offering to secure funding for advancing its clinical trials targeting cluster headaches and migraines.
25 Aug, 06:34 — 25 Aug, 06:34
Sources
Showing 1 of 1 sources
Related Stories
Italy Extends Diesel Fuel Tax Cut Through Early September
20m ago
Cisco Abandons Traditional Hardware Restrictions to Pursue AI Infrastructure Boom
31m ago
Executives at Itron and Lyft Sell Significant Company Stock Holdings
32m ago
Senior Official Firmly Rejects External Political Pressure and Influence Attempts
32m ago